






































































BRIEF REPORT • CID 2018:XX (XX XXXX) • 1
First Human Case of Metacestode 
Infection Caused by Versteria sp. in a 
Kidney Transplant Recipient
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Cestodes are emerging agents of severe opportunistic infec-
tions among immunocompromised patients. We describe the 
first case of human infection, with the recently-proposed genus 
Versteria causing an invasive, tumor-like hepatic infection with 
regional and distant extension in a 53-year-old female kidney 
transplant recipient from Atlantic Canada.
Keywords. metacestode infection; Versteria; kidney trans-
plant recipient; immunosuppression; zoonosis.
A 53-year-old Caucasian female from rural New Brunswick 
(Atlantic Canada) presented to a community hospital in April 
2017 with a 3-day history of fever, productive cough, myalgia, 
malaise, and anorexia. Her past medical history was remarkable 
for obstructive nephropathy necessitating a kidney transplant 
in 1992, for which she was on minimal immunosuppression 
with tacrolimus, mycophenolate mofetil, and prednisone (5 mg 
thrice weekly). Physical examination revealed a temperature of 
40ºC, oxygen saturation of 93% on 2L/min, hypotension, and 
tachycardia. The rest of the physical exam was noted as unre-
markable. Laboratory findings on admission were notable for 
mild pancytopenia, decreased kidney function compared to 
baseline (estimated CrCl 22  mL/min), transaminitis (~8X 
normal), and elevated lactate dehydrogenase (Supplementary 
Table 1). A chest X-ray revealed bibasilar alveolar opacities as 
more prominent in the right lung. Empiric antibacterial ther-
apy was initiated for presumed community-acquired pneumo-
nia and the patient was transferred to a tertiary care centre for 
further evaluation.
Despite empiric meropenem, recurrent episodes of hypoten-
sion required vasopressors and repeated admissions to the inten-
sive care unit. A chest computed tomography (CT) scan showed 
mixed alveolar ground glass opacities and a prominent right 
hilar lymph node (3.9 × 2 cm). Abdominal imaging revealed a 
large heterogeneous central hepatic lesion (19.3 × 15 × 8.7 cm) 
abutting the middle hepatic and left portal veins, with multiple 
satellite nodules (Figures 1 and 2). An abdominal CT scan per-
formed 3 years earlier was unremarkable. Further tests—includ-
ing a cerebral CT scan, a transesophageal echocardiogram, and 
a colonoscopy—revealed no other lesions. A laparoscopic liver 
biopsy revealed extensive necrosis, with focal necrotizing granu-
lomas surrounding hooklets and a single protoscolex, consistent 
with a metacestode infection (Figure 3). Empiric treatment with 
albendazole for possible alveolar echinococcosis (AE) was initi-
ated, and the patient was transferred to the J.D. MacLean Centre 
for Tropical Diseases in Montreal for further management.
Notable exposure history included living near a forest with 
her dog and with peridomestic wildlife such as foxes, coyotes, 
moose, deer, small rodents, and mustelids. She enjoys garden-
ing and blueberry picking and drinks water from a surface well. 
She never traveled outside Canada, and noted a single 4-day trip 
to Edmonton (Canada) in 1980.
A whole-body positron emission tomography scan with 
2-deoxy-2-[fluorine-18] fluoro-D-glucose integrated with 
CT (WB 18F-FDG PET/CT Scan) demonstrated low cervical, 
mediastinal, bilateral hilar, right axillary, and periportal ade-
nopathy, as well as intense heterogeneous uptake of FDG in the 
liver. Histopathology of a biopsy of the right hilar lymph node 
performed by endobronchial ultrasound revealed granuloma-
tous inflammation with extensive necrosis. Bacterial, mycobac-
terial, and fungal cultures were negative. The hepatic lesion was 
not considered resectable.
A screening enzyme-linked immunoassay (ELISA) using 
in-house crude antigens for Echinococcus granulosus was pos-
itive, with an optical density of 0.60 (cut-off value: 0.35). A sec-
ond ELISA using an E. granulosis hydatid fluid antigen (EgHF) 
as previously described was also positive (156 AU/ml; cut-off 
≥ 1 AU/ml) [1]. For E. multilocularis, 2 separate ELISAs, using 
(1) purified Em2 antigen (localized in the laminated layer) or 
(2) recombinant Em18 antigen (previously known as EmII/3-
10-antigen, localized in the tegument of the protoscolex and 
the germinal layer) were negative [2, 3]. Confirmatory Western 
blots for E. granulosus and E. multilocularis were performed as 
previously described, and were negative as well [1, 4].
Needle biopsies of the liver were repeated and sent for molecular 
testing at the University of Bern, Switzerland. Deoxyribonucleic 
acid (DNA) was extracted from a fresh-frozen native biopsy 
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specimen using a commercial kit, according to the manufacturer’s 
instructions (QiAmp DNA mini kit, Qiagen, Hilden, Germany). 
In addition, DNA was also prepared from formalin-fixed par-
affin-embedded liver tissue, as described by Müller et  al. [5]. 
Multiplex polymerase chain reaction (PCR) targeting mitochon-
drial 12S rDNA for discrimination between different cestodes was 
performed as previously described [6]. E. granulosus and E. multi-
locularis can be identified directly, based on the size of their PCR 
product. A 264 base pair (bp) fragment was amplified from both 
fresh-frozen and paraffin-embedded specimens, corresponding to 
neither E. granulosus nor E. multilocularis. DNA sequencing of the 
PCR product was thus performed to identify the cestode.
Primers CEST3 and CEST5 were used for bidirectional 
sequencing of the PCR amplification product, as previously 
described [6]. Amplicons were purified using the Qiagen PCR 
purification kit (Qiagen, Hilden, Germany) and sequenced using 
the Microsynth DNA sequencing service (Balgach, Switzerland). 
Basic Local Alignment Search Tool (BLAST) analysis yielded 98% 
identity with a sequence from a single reported case in a hominid: 
a fatal metacestode infection in a captive orangutan (Versteria sp., 
orangutan, Wisconsin; GenBank accession number: KF303341) 
[7]. Sequence data from the current case were deposited at 
GenBank (GenBank accession number: MH299497).
 Striking similarities in the clinical, radiological, and histo-
pathological features of this case with those of AE, and the high 
genetic relatedness of Versteria and Echinococcus, prompted us 
to manage our patient based on AE literature [8]. Antiparasitic 
therapy, combined with surgery, are the cornerstones of man-
agement. Our patient was treated with albendazole (15 mg/kg/
day), to which we added praziquantel (50 mg/kg/day) for com-
bination therapy. After 8 weeks, significant clinical improve-
ment was noted, with complete resolution of both fever and 
hypotension. A  liver magnetic resonance imaging scan per-
formed after 7 months of continuous treatment revealed a 50% 
decrease in the size of the liver lesion, with residual satellite 
lesions (Figure 4). Praziquantel is not usually recommended for 
AE. However, because radical resection of the liver lesion was 
not possible, we opted for the addition of praziquantel to maxi-
mize potential protoscolicidal effects.
Experience with AE suggests that unresected dissemi-
nated disease should prompt lifelong antiparasitic treatment. 
Albendazole sulfoxide drug monitoring proved valuable 
for optimal dosing and managing toxicity. It was conducted 
monthly on serum drawn 4 hours post–morning dose (target 
1–3 µmol/L) [8].
Figure  1. Axial T2-weighted magnetic resonance imaging scan of the liver, 
showing a large lesion occupying segments 3 and 4, with multiple satellite lesions 
(arrows), before initiation of albendazole and praziquantel.
Figure  2. Coronal T2-weighted magnetic resonance imaging scan of the liver, 
showing a large lesion occupying segments 3 and 4, with multiple satellite lesions, 
before initiation of albendazole and praziquantel
Figure  3. Hematoxylin and eosin staining of histopathology section, showing 
partial section through the parasite larvae with parts of a rostellum and a paren-
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Partial liver resection for AE yields poor outcomes [8]. Liver 
allotransplantation has been performed in the context of com-
plications such as cholangitis, secondary biliary cirrhosis, portal 
hypertension, hepatic hilar invasion, and Budd-Chiari syn-
drome, and has shown a 5-year survival rate of 66.7 to 71% [8]. 
In the current case, these complications were not observed and, 
after 7 months of combination chemotherapy, we documented 
a 50% decrease in the size of the liver lesion and resolution of 
many satellite lesions. Long-term follow-up with imaging and 
albendazole sulfoxide drug monitoring is planned.
The impact of immunosuppression on infections with meta-
cestodes such as Echinococcus multilocularis is well described, 
often leading to rapidly-invasive progression and dissemin-
ation, reminiscent of malignancy [9]. This first human case of 
Versteria sp. infection, particularly in a kidney transplant recip-
ient, is in keeping with these observations, including distant 
intrathoracic lymph node involvement. A documented normal 
abdominal CT scan 3 years prior to admission testifies to a rel-
atively rapid disease progression. A Versteria infection reported 
in a captive Bornean orangutan in Milwaukee, Wisconsin, was 
also rapid, proved fatal, and involved the liver, lung, and spleen, 
although no immunosuppression was documented [7].
In our case, the patient presented with severe pulmonary 
and systemic symptoms, presumably attributed to extrahe-
patic dissemination of the infection. Along with the fever, the 
patient had multiple episodes of hypotension. We speculate that 
these episodes may be related to intermittent antigen release, 
resulting in a type I hypersensitivity reaction as described with 
E. granulosus and, less frequently, with E. multilocularis.
The clinical presentation, radiological findings, and inflam-
matory necrosis seen on histopathology were reminiscent of 
alveolar echinococcosis, but AE has never been described in 
humans or animals in the Eastern half of North America [10]. 
The histopathological appearance of the protoscolex and hook-
lets were not typical of E. multilocularis. Seen in less than 5% of 
human AE cases, the protoscolex of E.multilocularis is a circular, 
invaginated scolex with rostellar hooks of clearly-defined sizes 
and shapes (21–20 µm length and a ratio of the basis-length and 
bow-height of 1:3.4). By contrast, the metacestode of Versteria 
sp. (Figure 3) is a cysticercus-strobilocercus–like larvae whose 
scolex and rostellar hook dimensions are different from E. mul-
tilocularis [11]. Positive serology using crude antigens, as well 
as EgHF antigen for E. granulosus, likely reflects cross-reactiv-
ity between genera. Cross-reactivity was not observed with the 
E. multilocularis ELISAs, nor in the confirmatory Western blots.
Efforts to better characterize the definitive host of Versteria 
in North America have demonstrated at least 2 circulating 
parasite genetic lineages, representing separate introductions 
from Eurasia [12]. The definitive hosts of Versteria spp. are wild 
mustelids (eg, mink, ermine) and the intermediate hosts are 
rodents.
Sequence analysis of Versteria sp. found in feces of an ermine 
in Colorado, a mink in Oregon, the deceased index orangutan, 
and our patient all suggest a single lineage [12]. In the United 
States, Versteria sp. has also been reported in Wisconsin and 
Idaho. While both parasite genetic lineages have been found 
in the Northwest Territories of Canada, circulation of either 
has not been described anywhere else in the country [12]. We 
hypothesize that this immunocompromised patient acted as an 
accidental host.
Versteria sp. is a newly-recognized zoonosis and must be 
considered in the differential diagnosis of alveolar echino-
coccosis in immunocompromised patients from endemic 
areas. Unlike AE, combination medical therapy without sur-
gery showed promising results. Distinguishing between AE 
and Versteria infection may thus have important prognostic 
significance.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online. 
Consisting of data provided by the authors to benefit the reader, the posted 
materials are not copyedited and are the sole responsibility of the authors, 
so questions or comments should be addressed to the corresponding author.
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Figure 4. Axial T2-weighted magnetic resonance imaging scan of the liver, show-
ing a large lesion occupying segments 4, with residual satellite lesions 7 months 
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